AMA president Dr Michael Gannon has drawn ire for telling pharmacists to “stick to their knitting” over pathology tests
After Sigma announced that it would offer pathology health screenings throughout its Amcal Pharmacy network from June 26, 2017, the AMA slammed the initiative as “opportunistic, wasteful and bordering on irresponsible”.
AMA president Dr Michael Gannon took to Twitter to express his displeasure.
— AMA President (@amapresident) June 29, 2017
The comment didn’t go down well.
Your derogatory comments are an embarrassment to your organisation. @ama_media time to put a leash on this twitter account.
— Sam Turner (@sdturner7) June 30, 2017
The PSA’s Dr Lance Emerson suggested that Dr Gannon familiarise himself with the PSA’s position on evidence-based screening and risk assessment in pharmacies, while the NSW Guild’s Rick Samimi suggested a parallel with another high-profile Twitter user.
— Rick Samimi (@RickSamimi) June 30, 2017
Mr Samimi was one of several who suggested similarities to the US president’s unique Twitter style.
You been taking Twitter lessons from @realDonaldTrump ? You can criticize an idea or practice without insulting an entire profession!
— Greg Oldridge (@GregOldridge) July 1, 2017
One correspondent suggested that Dr Gannon look to the next generation of practitioners for ways of working together.
— Lauren Haworth (@laurenmhaworth) June 30, 2017
And a few Twitter users at least had some constructive advice as to how to move on from here.
We should use this opportunity for interprofessional colloboration and dialogue. We need to understand each other's roles to facilitate care
— Zainab R. (@Zainab_Pharm) July 1, 2017